Davidra Nicole Sajna
Voorzitter bij Hoverink Biotechnologies, Inc.
Vermogen: 249 $ op 30-11-2018
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Cyrus Sajna | M | 42 |
Hoverink Biotechnologies, Inc.
 Hoverink Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Hoverink Biotechnologies, Inc. operates as a biopharmaceutical company, which discovers, develops, manufactures, and commercializes pharmaceutical preparations and drug treatment for age-related diseases, cancer, gastrointestinal and oncological diseases and disorders. Its product candidate includes Ladavru, which is developed for treating cirrhosis ascites, cirrhosis, AIDS, and chronic pain, nausea and discomfort associated with chemotherapy. The company was founded by Cyrus Sajna on July 2, 2013 and is headquartered in Los Angeles, CA. | 11 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| James Cassidy | M | 88 |
Hoverink Biotechnologies, Inc.
Hoverink Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Hoverink Biotechnologies, Inc. operates as a biopharmaceutical company, which discovers, develops, manufactures, and commercializes pharmaceutical preparations and drug treatment for age-related diseases, cancer, gastrointestinal and oncological diseases and disorders. Its product candidate includes Ladavru, which is developed for treating cirrhosis ascites, cirrhosis, AIDS, and chronic pain, nausea and discomfort associated with chemotherapy. The company was founded by Cyrus Sajna on July 2, 2013 and is headquartered in Los Angeles, CA. | - |
| Debbie Carter | F | - |
Hoverink Biotechnologies, Inc.
Hoverink Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Hoverink Biotechnologies, Inc. operates as a biopharmaceutical company, which discovers, develops, manufactures, and commercializes pharmaceutical preparations and drug treatment for age-related diseases, cancer, gastrointestinal and oncological diseases and disorders. Its product candidate includes Ladavru, which is developed for treating cirrhosis ascites, cirrhosis, AIDS, and chronic pain, nausea and discomfort associated with chemotherapy. The company was founded by Cyrus Sajna on July 2, 2013 and is headquartered in Los Angeles, CA. | 5 jaar |
| James McKillop | M | 64 |
Hoverink Biotechnologies, Inc.
Hoverink Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Hoverink Biotechnologies, Inc. operates as a biopharmaceutical company, which discovers, develops, manufactures, and commercializes pharmaceutical preparations and drug treatment for age-related diseases, cancer, gastrointestinal and oncological diseases and disorders. Its product candidate includes Ladavru, which is developed for treating cirrhosis ascites, cirrhosis, AIDS, and chronic pain, nausea and discomfort associated with chemotherapy. The company was founded by Cyrus Sajna on July 2, 2013 and is headquartered in Los Angeles, CA. | - |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 4 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Davidra Nicole Sajna
- Persoonlijk netwerk
